Huijuan Yang , Jian Zhang , Rujiao Liu , Shuiping Gao , Hanmei Lou , Guiling Li , Hualei Bu , Rong Li , Shanbing Wang , Shujing Shen , Mingjun Zhang , Peipei Wang , Zhe Feng , Nan Chu
{"title":"针对 Nectin-4 的抗体药物共轭物 9 MW2821 单药治疗复发性或转移性宫颈癌患者的疗效和安全性:一项多中心、开放标签的 I/II 期研究","authors":"Huijuan Yang , Jian Zhang , Rujiao Liu , Shuiping Gao , Hanmei Lou , Guiling Li , Hualei Bu , Rong Li , Shanbing Wang , Shujing Shen , Mingjun Zhang , Peipei Wang , Zhe Feng , Nan Chu","doi":"10.1016/j.ygyno.2024.07.039","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":12853,"journal":{"name":"Gynecologic oncology","volume":null,"pages":null},"PeriodicalIF":4.5000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy and safety of 9 MW2821, an antibody-drug conjugate targeting Nectin-4 monotherapy, in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, phase I/II study\",\"authors\":\"Huijuan Yang , Jian Zhang , Rujiao Liu , Shuiping Gao , Hanmei Lou , Guiling Li , Hualei Bu , Rong Li , Shanbing Wang , Shujing Shen , Mingjun Zhang , Peipei Wang , Zhe Feng , Nan Chu\",\"doi\":\"10.1016/j.ygyno.2024.07.039\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":12853,\"journal\":{\"name\":\"Gynecologic oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gynecologic oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0090825824003949\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0090825824003949","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
Efficacy and safety of 9 MW2821, an antibody-drug conjugate targeting Nectin-4 monotherapy, in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, phase I/II study
期刊介绍:
Gynecologic Oncology, an international journal, is devoted to the publication of clinical and investigative articles that concern tumors of the female reproductive tract. Investigations relating to the etiology, diagnosis, and treatment of female cancers, as well as research from any of the disciplines related to this field of interest, are published.
Research Areas Include:
• Cell and molecular biology
• Chemotherapy
• Cytology
• Endocrinology
• Epidemiology
• Genetics
• Gynecologic surgery
• Immunology
• Pathology
• Radiotherapy